Optimized Collection Protocol for Plasma MicroRNA Measurement in Patients with Cardiovascular Disease

Table 2

Expression of miRNA (ct value) at 0 h and 2 h.

miRNA	0 h	2 h
	Median ± SD	Median ± SD
hsa-miR-15b-5p	30.55 ± 0.98	29.75 ± 1.07	0.0315^†
hsa-miR-17-5p	29 ± 1.08	29.43 ± 1.19	0.3401
hsa-miR-19a-3p	29.85 ± 0.96	31.39 ± 1.25	0.3865
hsa-miR-20a-5p	32.98 ± 1.05	32.09 ± 1.08	0.1135
hsa-miR-21-5p	32.29 ± 0.87	32.43 ± 0.97	0.7962
hsa-miR-24-3p	28.37 ± 1.17	28.06 ± 1.26	0.8633
hsa-miR-27a-3p	30.04 ± 0.96	29.7 ± 1	0.2581
hsa-miR-27b-3p	30.35 ± 0.99	30.59 ± 1.01	1
hsa-miR-30c-5p	33.07 ± 0.98	32.78 ± 0.88	0.7962
hsa-miR-30e-5p	34.25 ± 1.11	32.84 ± 1.06	0.0315^†
hsa-miR-145-5p	32.01 ± 0.8	31.31 ± 1.12	0.2581
hsa-miR-150-5p	29.84 ± 0.86	30.31 ± 0.61	0.2973
hsa-miR-199a-3p	31.51 ± 1.51	30.78 ± 1.95	0.7304
hsa-miR-210	33.6 ± 1.19	33.5 ± 1.15	0.3401
hsa-miR-221-3p	29.06 ± 1.25	29.82 ± 1.43	0.6665
hsa-miR-222-3p	31.12 ± 0.89	30.65 ± 0.92	0.1615
hsa-miR-320a	28.26 ± 0.86	28.85 ± 0.8	0.2224
hsa-miR-423-5p	28.81 ± 1.11	28.52 ± 1.07	0.4363

Mann–Whitney test.
^†Statistically significant.